Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications.

Autor: Akıncı S; Department of Cardiology, Başkent University Faculty of Medicine Alanya Application and Research Center, Antalya, Turkey., Çoner A; Department of Cardiology, Başkent University Faculty of Medicine Alanya Application and Research Center, Antalya, Turkey., Akbay E; Department of Cardiology, Başkent University Faculty of Medicine Alanya Application and Research Center, Antalya, Turkey., Adar A; Department of Cardiology, Başkent University Faculty of Medicine Alanya Application and Research Center, Antalya, Turkey., Müderrisoğlu H; Department of Cardiology, Başkent University Faculty of Medicine, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir [Turk Kardiyol Dern Ars] 2022 Oct; Vol. 50 (7), pp. 545-546.
DOI: 10.5543/tkda.2022.220922
Databáze: MEDLINE